Featured full episode August 24, 2026
The DEA’s Shift on Marijuana: What You Need to Know
Watch here in privacy-enhanced mode, or open the exact episode on YouTube.
What changed this week
The laws, lawsuits, political fights, and business moves shaping cannabis—with the source links attached.
Watch first
Featured full episode August 24, 2026
Watch here in privacy-enhanced mode, or open the exact episode on YouTube.
The Illinois Department of Agriculture proposed letting cultivation centers and craft growers grow outdoors — behind 8-foot fencing topped with razor wire. Comments close September 28.
Post-hearing briefs in the DEA rescheduling proceeding are due August 17. Here is what the deadline means, who is filing, and why a final answer is still months…
Illinois posted the form letting adult-use dispensaries opt into a medical license. Filing opens September 10 and costs $5,000 — and Schedule III is the reason it matters.
The VA psilocybin trial, called PIVOT, is a Phase 3 study in veterans with treatment-resistant depression. Nobody has been dosed yet.
A new law lets New York cannabis microbusinesses satisfy the showcase permit partnership rule themselves — but OCM guidance has not caught up yet.
Wisconsin deputies used Flock cameras to log a driver crossing into Michigan, then wrote that travel into a probable cause narrative for a marijuana search.
CDC data show cannabis hyperemesis ER visits rose 3.7x after a new diagnosis code — but the agency says the jump is mostly better counting, not more illness.
James Talarico calls the Texas THC ban an "insane" form of corruption benefiting Big Beer and Big Tobacco. Here is what actually changed on July 31.
A labor peace agreement lawsuit filed by Verano asks a federal court to void its own union contracts and strike New Jersey licensing rules as preempted.
The Square CBD ban gives merchants until October 15, 2026 to strip hemp and CBD items from their catalogs — a month before the federal date.